Investors

Bioasis Technologies, Inc. is a science-driven company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain. Our goal is to generate shareholder value by developing and commercializing our proprietary brain delivery technology, xB3, to make life-saving drugs brain-penetrant and deliver those drugs at a therapeutically relevant dose.

All Public Filings (Canada)

Most Recent Financial Reports (US)

Corporate Presentation

Stock Quote

Investor News and Events

  • Jul. 29, 2021 Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A

    NEW HAVEN, Conn., July 29, 2021 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”),a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3TM platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including… Read more »

  • Jun. 29, 2021 Bioasis Technologies Announces Closing of Initial C$3,000,000 Funding by Lind Partners

    NEW HAVEN, Conn., June 29, 2021 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (“Bioasis” or the “Company”) (TSX.V:BTI; OTCQB:BIOAF), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatment of CNS disorders in areas of high unmet medical need, including brain… Read more »

  • Jun. 25, 2021 Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A

    NEW HAVEN, Conn., June 25, 2021 (GLOBE NEWSWIRE) — Bioasis Technologies, Inc. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need,… Read more »

All Events and Presentations